Disc Medicine stock closes at $56.84 below all three daily EMAs

Disc Medicine stock displays a bearish daily setup, despite positive Phase 3 trial reports published after the latest completed session. The distinction matters: Friday’s chart shows price below all three daily exponential averages, while Monday’s news presents a separate development. Key takeaways Disc Medicine stock closed at $56.84 on Friday, October 16, below the daily 20-session EMA ($62.49), 50-session EMA ($67.96), and 200-session EMA ($70.5). Daily RSI14 is 25.29 , inside oversold territory; daily MACD histogram is -0.33, with the MACD line at -4.07 below its signal at -3.74. Hourly RSI14 is 44.32, below 50; hourly MACD histogram is 0.14, with the MACD line at -0.6 above its signal at -0.74. Positive Phase 3 APOLLO trial results for bitopertin were reported on Monday, October 19, after Friday’s close.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to The Cryptonomist.